Investing Profile

Heath Lukatch

VCInvestorFounder
Founder & Managing Partner at Red Tree Venture Capital
redtreevc.com/team/San Francisco, California
Photo of Heath Lukatch, Managing Partner at Red Tree Venture Capital
cb
Red Tree Venture Capital Managing Partner
$100K - $5.0M
$1.5M
24
CompanyStageDateRound SizeTotal Raised
Engrail Therapeutics
Series BMar 2024$160M
$220M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Niall O’Donnell (RiverVest), Peter Bisgaard (Pivotal bioVenture Partners), Jasper Bos (Forbion)
Tachyon Therapeutics
Series AMar 2023$12M
$12M
Alladapt Immunotherapeutics
Series UnknownJun 2022$120M
$230M
Co-investors: Jeff Weiner (Next Play Ventures), Himani Bhalla (Hercules Capital), Anne Wojcicki
Magnus Medical
Series AOct 2021$25M
$25M
Co-investors: Andrew Firlik (Jazz Venture Partners)
Acrigen Biosciences
SeedSep 2021
ViaCyte
Series DNov 2018$80M
$140M
Co-investors: Asish Xavier (Johnson & Johnson Innovation), Adam Koppel (Bain Capital Life Sciences)
Halo Neuroscience
Series BJan 2018$13M
$24M
Co-investors: Jeff Clavier (Uncork Capital), Fabrice Grinda (FJ Labs), Marc Andreessen (Andreessen Horowitz), Patrick Chung (Xfund), Patrick S. Chung
Engage Therapeutics
Series ASep 2017$24M
$24M